A s the new director of public policy for AIBS, I wanted to take this opportunity to discuss one of the eleven initiatives from the 1999 AIBS Presidents' Summit: making the case for biology. Little did we know how much the success of the "other" biology, biomedical studies, would complicate that task. Congressional appropriators have repeatedly heard about the imbalance in federal funding between the life and physical sciences. There is a sense that the life sciences have received their fair share through the NIH budget increase. Perhaps as evidence of this sentiment, the Biological Sciences Directorate of NSF received only half of the increase granted to most other directorates for fiscal year 2002.
